Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 6Other hematologic neoplasm 4Plasma cell 3Genitourinary 3Head & Neck 2Dermatologic 2Classical hematology 2CNS 2Other neoplasm 1Myeloid 1

Conditions

Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Infections 1Cystectomy 1

Interventions

Docetaxel 409pembrolizumab 332Prednisone 290enzalutamide 285Gemcitabine 274Radiotherapy 270Magnetic Resonance Spectroscopy 269Nivolumab 253Abiraterone Acetate 218Cisplatin 212Leuprolide 195Radiosurgery 192Sunitinib 188Carboplatin 161Androgen Antagonists 156bicalutamide 152Specimen Handling 149Goserelin 149Ipilimumab 131Paclitaxel 126acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 122apalutamide 118Cyclophosphamide 117Bevacizumab 116Sorafenib 114Everolimus 111abiraterone 108cabozantinib 105atezolizumab 105Biopsy 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Amoxicillin-Potassium Clavulanate Combination × Genitourinary × Clear all
NCT06709196 2025-01-09

REINFORCE

Rigshospitalet, Denmark

Phase 4 Recruiting
248 enrolled
Genitourinary

Cystectomy

NCT05392634 2022-05-31

MACS

N.N. Petrov National Medical Research Center of Oncology

Phase 3 Unknown
98 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT03228108 2022-05-10

pro-SWAP

Radboud University Medical Center

Phase 4 Completed
1,538 enrolled
Genitourinary

Infections, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡